Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer (Q44257515)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer |
scientific article |
Statements
1 reference
Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer (English)
1 reference
Z-H Niu
1 reference
Y Wang
1 reference
B Chun
1 reference
C-X Li
1 reference
L Wu
1 reference
1 May 2013
1 reference
1 reference
17
1 reference
10
1 reference
1337-1344
1 reference
Identifiers
1 reference